4//SEC Filing
Katabi Maha 4
Accession 0001415889-24-000704
CIK 0001798749other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:00 PM ET
Size
5.8 KB
Accession
0001415889-24-000704
Insider Transaction Report
Form 4
Katabi Maha
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-01-02$13.49/sh+3,519$47,471→ 3,519 totalExercise: $21.81Exp: 2034-01-01→ Common Stock (3,519 underlying)
Footnotes (1)
- [F1]This option was awarded in lieu of cash compensation pursuant to the Issuer's Non-Employee Director Compensation Policy. The shares underlying such option shall vest and become exercisable in four equal installments, with the first installment vesting on March 31, 2024, the second installment vesting on June 30, 2024, the third installment vesting on September 30, 2024, and the fourth installment vesting on December 31, 2024.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001720685
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 6:00 PM ET
- Size
- 5.8 KB